[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Particle Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

July 2022 | 100 pages | ID: GD3033A7BBA9EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Particle Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Particle Therapy market size is estimated to be worth US$ 791.1 million in 2021 and is forecast to a readjusted size of USD 1116.6 million by 2028 with a CAGR of 5.0% during review period. Pediatric Cancer accounting for % of the Particle Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Proton Therapy segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Particle Therapy include Varian Medical Systems, Ion Beam Applications Sa (IBA), Mevion Medical Systems, Inc., Provision Healthcare, LLC, and Sumitomo Heavy Industries, Ltd., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Particle Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
  • Proton Therapy
  • Heavy Ion Therapy
Market segment by Application, can be divided into
  • Pediatric Cancer
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Other Cancers
Market segment by players, this report covers
  • Varian Medical Systems
  • Ion Beam Applications Sa (IBA)
  • Mevion Medical Systems, Inc.
  • Provision Healthcare, LLC
  • Sumitomo Heavy Industries, Ltd.
  • Hitachi, Ltd.
  • Optivus Proton Therapy, Inc.
  • Protom International, Inc.
  • Advanced Oncotherapy PLC.
  • Danfysik A/S
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Particle Therapy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Particle Therapy, with revenue, gross margin and global market share of Particle Therapy from 2019 to 2022.

Chapter 3, the Particle Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Particle Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Particle Therapy research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Particle Therapy
1.2 Classification of Particle Therapy by Type
  1.2.1 Overview: Global Particle Therapy Market Size by Type: 2017 Versus 2021 Versus 2028
  1.2.2 Global Particle Therapy Revenue Market Share by Type in 2021
  1.2.3 Proton Therapy
  1.2.4 Heavy Ion Therapy
1.3 Global Particle Therapy Market by Application
  1.3.1 Overview: Global Particle Therapy Market Size by Application: 2017 Versus 2021 Versus 2028
  1.3.2 Pediatric Cancer
  1.3.3 Prostate Cancer
  1.3.4 Breast Cancer
  1.3.5 Lung Cancer
  1.3.6 Head and Neck Cancer
  1.3.7 Other Cancers
1.4 Global Particle Therapy Market Size & Forecast
1.5 Global Particle Therapy Market Size and Forecast by Region
  1.5.1 Global Particle Therapy Market Size by Region: 2017 VS 2021 VS 2028
  1.5.2 Global Particle Therapy Market Size by Region, (2017-2022)
  1.5.3 North America Particle Therapy Market Size and Prospect (2017-2028)
  1.5.4 Europe Particle Therapy Market Size and Prospect (2017-2028)
  1.5.5 Asia-Pacific Particle Therapy Market Size and Prospect (2017-2028)
  1.5.6 South America Particle Therapy Market Size and Prospect (2017-2028)
  1.5.7 Middle East and Africa Particle Therapy Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Particle Therapy Market Drivers
  1.6.2 Particle Therapy Market Restraints
  1.6.3 Particle Therapy Trends Analysis

2 COMPANY PROFILES

2.1 Varian Medical Systems
  2.1.1 Varian Medical Systems Details
  2.1.2 Varian Medical Systems Major Business
  2.1.3 Varian Medical Systems Particle Therapy Product and Solutions
  2.1.4 Varian Medical Systems Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.1.5 Varian Medical Systems Recent Developments and Future Plans
2.2 Ion Beam Applications Sa (IBA)
  2.2.1 Ion Beam Applications Sa (IBA) Details
  2.2.2 Ion Beam Applications Sa (IBA) Major Business
  2.2.3 Ion Beam Applications Sa (IBA) Particle Therapy Product and Solutions
  2.2.4 Ion Beam Applications Sa (IBA) Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.2.5 Ion Beam Applications Sa (IBA) Recent Developments and Future Plans
2.3 Mevion Medical Systems, Inc.
  2.3.1 Mevion Medical Systems, Inc. Details
  2.3.2 Mevion Medical Systems, Inc. Major Business
  2.3.3 Mevion Medical Systems, Inc. Particle Therapy Product and Solutions
  2.3.4 Mevion Medical Systems, Inc. Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.3.5 Mevion Medical Systems, Inc. Recent Developments and Future Plans
2.4 Provision Healthcare, LLC
  2.4.1 Provision Healthcare, LLC Details
  2.4.2 Provision Healthcare, LLC Major Business
  2.4.3 Provision Healthcare, LLC Particle Therapy Product and Solutions
  2.4.4 Provision Healthcare, LLC Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.4.5 Provision Healthcare, LLC Recent Developments and Future Plans
2.5 Sumitomo Heavy Industries, Ltd.
  2.5.1 Sumitomo Heavy Industries, Ltd. Details
  2.5.2 Sumitomo Heavy Industries, Ltd. Major Business
  2.5.3 Sumitomo Heavy Industries, Ltd. Particle Therapy Product and Solutions
  2.5.4 Sumitomo Heavy Industries, Ltd. Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.5.5 Sumitomo Heavy Industries, Ltd. Recent Developments and Future Plans
2.6 Hitachi, Ltd.
  2.6.1 Hitachi, Ltd. Details
  2.6.2 Hitachi, Ltd. Major Business
  2.6.3 Hitachi, Ltd. Particle Therapy Product and Solutions
  2.6.4 Hitachi, Ltd. Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.6.5 Hitachi, Ltd. Recent Developments and Future Plans
2.7 Optivus Proton Therapy, Inc.
  2.7.1 Optivus Proton Therapy, Inc. Details
  2.7.2 Optivus Proton Therapy, Inc. Major Business
  2.7.3 Optivus Proton Therapy, Inc. Particle Therapy Product and Solutions
  2.7.4 Optivus Proton Therapy, Inc. Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.7.5 Optivus Proton Therapy, Inc. Recent Developments and Future Plans
2.8 Protom International, Inc.
  2.8.1 Protom International, Inc. Details
  2.8.2 Protom International, Inc. Major Business
  2.8.3 Protom International, Inc. Particle Therapy Product and Solutions
  2.8.4 Protom International, Inc. Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.8.5 Protom International, Inc. Recent Developments and Future Plans
2.9 Advanced Oncotherapy PLC.
  2.9.1 Advanced Oncotherapy PLC. Details
  2.9.2 Advanced Oncotherapy PLC. Major Business
  2.9.3 Advanced Oncotherapy PLC. Particle Therapy Product and Solutions
  2.9.4 Advanced Oncotherapy PLC. Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.9.5 Advanced Oncotherapy PLC. Recent Developments and Future Plans
2.10 Danfysik A/S
  2.10.1 Danfysik A/S Details
  2.10.2 Danfysik A/S Major Business
  2.10.3 Danfysik A/S Particle Therapy Product and Solutions
  2.10.4 Danfysik A/S Particle Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
  2.10.5 Danfysik A/S Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Particle Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
  3.2.1 Top 3 Particle Therapy Players Market Share in 2021
  3.2.2 Top 10 Particle Therapy Players Market Share in 2021
  3.2.3 Market Competition Trend
3.3 Particle Therapy Players Head Office, Products and Services Provided
3.4 Particle Therapy Mergers & Acquisitions
3.5 Particle Therapy New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Particle Therapy Revenue and Market Share by Type (2017-2022)
4.2 Global Particle Therapy Market Forecast by Type (2023-2028)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Particle Therapy Revenue Market Share by Application (2017-2022)
5.2 Global Particle Therapy Market Forecast by Application (2023-2028)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Particle Therapy Revenue by Type (2017-2028)
6.2 North America Particle Therapy Revenue by Application (2017-2028)
6.3 North America Particle Therapy Market Size by Country
  6.3.1 North America Particle Therapy Revenue by Country (2017-2028)
  6.3.2 United States Particle Therapy Market Size and Forecast (2017-2028)
  6.3.3 Canada Particle Therapy Market Size and Forecast (2017-2028)
  6.3.4 Mexico Particle Therapy Market Size and Forecast (2017-2028)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Particle Therapy Revenue by Type (2017-2028)
7.2 Europe Particle Therapy Revenue by Application (2017-2028)
7.3 Europe Particle Therapy Market Size by Country
  7.3.1 Europe Particle Therapy Revenue by Country (2017-2028)
  7.3.2 Germany Particle Therapy Market Size and Forecast (2017-2028)
  7.3.3 France Particle Therapy Market Size and Forecast (2017-2028)
  7.3.4 United Kingdom Particle Therapy Market Size and Forecast (2017-2028)
  7.3.5 Russia Particle Therapy Market Size and Forecast (2017-2028)
  7.3.6 Italy Particle Therapy Market Size and Forecast (2017-2028)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Particle Therapy Revenue by Type (2017-2028)
8.2 Asia-Pacific Particle Therapy Revenue by Application (2017-2028)
8.3 Asia-Pacific Particle Therapy Market Size by Region
  8.3.1 Asia-Pacific Particle Therapy Revenue by Region (2017-2028)
  8.3.2 China Particle Therapy Market Size and Forecast (2017-2028)
  8.3.3 Japan Particle Therapy Market Size and Forecast (2017-2028)
  8.3.4 South Korea Particle Therapy Market Size and Forecast (2017-2028)
  8.3.5 India Particle Therapy Market Size and Forecast (2017-2028)
  8.3.6 Southeast Asia Particle Therapy Market Size and Forecast (2017-2028)
  8.3.7 Australia Particle Therapy Market Size and Forecast (2017-2028)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Particle Therapy Revenue by Type (2017-2028)
9.2 South America Particle Therapy Revenue by Application (2017-2028)
9.3 South America Particle Therapy Market Size by Country
  9.3.1 South America Particle Therapy Revenue by Country (2017-2028)
  9.3.2 Brazil Particle Therapy Market Size and Forecast (2017-2028)
  9.3.3 Argentina Particle Therapy Market Size and Forecast (2017-2028)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Particle Therapy Revenue by Type (2017-2028)
10.2 Middle East & Africa Particle Therapy Revenue by Application (2017-2028)
10.3 Middle East & Africa Particle Therapy Market Size by Country
  10.3.1 Middle East & Africa Particle Therapy Revenue by Country (2017-2028)
  10.3.2 Turkey Particle Therapy Market Size and Forecast (2017-2028)
  10.3.3 Saudi Arabia Particle Therapy Market Size and Forecast (2017-2028)
  10.3.4 UAE Particle Therapy Market Size and Forecast (2017-2028)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

LIST OF TABLES

Table 1. Global Particle Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Particle Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Particle Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Particle Therapy Revenue (USD Million) by Region (2017-2022)
Table 5. Global Particle Therapy Revenue Market Share by Region (2023-2028)
Table 6. Varian Medical Systems Corporate Information, Head Office, and Major Competitors
Table 7. Varian Medical Systems Major Business
Table 8. Varian Medical Systems Particle Therapy Product and Solutions
Table 9. Varian Medical Systems Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Ion Beam Applications Sa (IBA) Corporate Information, Head Office, and Major Competitors
Table 11. Ion Beam Applications Sa (IBA) Major Business
Table 12. Ion Beam Applications Sa (IBA) Particle Therapy Product and Solutions
Table 13. Ion Beam Applications Sa (IBA) Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Mevion Medical Systems, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Mevion Medical Systems, Inc. Major Business
Table 16. Mevion Medical Systems, Inc. Particle Therapy Product and Solutions
Table 17. Mevion Medical Systems, Inc. Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Provision Healthcare, LLC Corporate Information, Head Office, and Major Competitors
Table 19. Provision Healthcare, LLC Major Business
Table 20. Provision Healthcare, LLC Particle Therapy Product and Solutions
Table 21. Provision Healthcare, LLC Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Sumitomo Heavy Industries, Ltd. Corporate Information, Head Office, and Major Competitors
Table 23. Sumitomo Heavy Industries, Ltd. Major Business
Table 24. Sumitomo Heavy Industries, Ltd. Particle Therapy Product and Solutions
Table 25. Sumitomo Heavy Industries, Ltd. Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Hitachi, Ltd. Corporate Information, Head Office, and Major Competitors
Table 27. Hitachi, Ltd. Major Business
Table 28. Hitachi, Ltd. Particle Therapy Product and Solutions
Table 29. Hitachi, Ltd. Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Optivus Proton Therapy, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Optivus Proton Therapy, Inc. Major Business
Table 32. Optivus Proton Therapy, Inc. Particle Therapy Product and Solutions
Table 33. Optivus Proton Therapy, Inc. Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Protom International, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Protom International, Inc. Major Business
Table 36. Protom International, Inc. Particle Therapy Product and Solutions
Table 37. Protom International, Inc. Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Advanced Oncotherapy PLC. Corporate Information, Head Office, and Major Competitors
Table 39. Advanced Oncotherapy PLC. Major Business
Table 40. Advanced Oncotherapy PLC. Particle Therapy Product and Solutions
Table 41. Advanced Oncotherapy PLC. Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Danfysik A/S Corporate Information, Head Office, and Major Competitors
Table 43. Danfysik A/S Major Business
Table 44. Danfysik A/S Particle Therapy Product and Solutions
Table 45. Danfysik A/S Particle Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Particle Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Particle Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Particle Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Particle Therapy Players Head Office, Products and Services Provided
Table 50. Particle Therapy Mergers & Acquisitions in the Past Five Years
Table 51. Particle Therapy New Entrants and Expansion Plans
Table 52. Global Particle Therapy Revenue (USD Million) by Type (2017-2022)
Table 53. Global Particle Therapy Revenue Share by Type (2017-2022)
Table 54. Global Particle Therapy Revenue Forecast by Type (2023-2028)
Table 55. Global Particle Therapy Revenue by Application (2017-2022)
Table 56. Global Particle Therapy Revenue Forecast by Application (2023-2028)
Table 57. North America Particle Therapy Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Particle Therapy Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Particle Therapy Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Particle Therapy Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Particle Therapy Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Particle Therapy Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Particle Therapy Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Particle Therapy Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Particle Therapy Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Particle Therapy Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Particle Therapy Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Particle Therapy Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Particle Therapy Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Particle Therapy Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Particle Therapy Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Particle Therapy Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Particle Therapy Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Particle Therapy Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Particle Therapy Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Particle Therapy Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Particle Therapy Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Particle Therapy Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Particle Therapy Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Particle Therapy Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Particle Therapy Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Particle Therapy Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Particle Therapy Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Particle Therapy Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Particle Therapy Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Particle Therapy Revenue by Country (2023-2028) & (USD Million)

LIST OF FIGURES

Figure 1. Particle Therapy Picture
Figure 2. Global Particle Therapy Revenue Market Share by Type in 2021
Figure 3. Proton Therapy
Figure 4. Heavy Ion Therapy
Figure 5. Particle Therapy Revenue Market Share by Application in 2021
Figure 6. Pediatric Cancer Picture
Figure 7. Prostate Cancer Picture
Figure 8. Breast Cancer Picture
Figure 9. Lung Cancer Picture
Figure 10. Head and Neck Cancer Picture
Figure 11. Other Cancers Picture
Figure 12. Global Particle Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Particle Therapy Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Particle Therapy Revenue Market Share by Region (2017-2028)
Figure 15. Global Particle Therapy Revenue Market Share by Region in 2021
Figure 16. North America Particle Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Particle Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Particle Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Particle Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Particle Therapy Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Particle Therapy Market Drivers
Figure 22. Particle Therapy Market Restraints
Figure 23. Particle Therapy Market Trends
Figure 24. Varian Medical Systems Recent Developments and Future Plans
Figure 25. Ion Beam Applications Sa (IBA) Recent Developments and Future Plans
Figure 26. Mevion Medical Systems, Inc. Recent Developments and Future Plans
Figure 27. Provision Healthcare, LLC Recent Developments and Future Plans
Figure 28. Sumitomo Heavy Industries, Ltd. Recent Developments and Future Plans
Figure 29. Hitachi, Ltd. Recent Developments and Future Plans
Figure 30. Optivus Proton Therapy, Inc. Recent Developments and Future Plans
Figure 31. Protom International, Inc. Recent Developments and Future Plans
Figure 32. Advanced Oncotherapy PLC. Recent Developments and Future Plans
Figure 33. Danfysik A/S Recent Developments and Future Plans
Figure 34. Global Particle Therapy Revenue Share by Players in 2021
Figure 35. Particle Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Particle Therapy Revenue Market Share in 2021
Figure 37. Global Top 10 Players Particle Therapy Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Particle Therapy Revenue Share by Type in 2021
Figure 40. Global Particle Therapy Market Share Forecast by Type (2023-2028)
Figure 41. Global Particle Therapy Revenue Share by Application in 2021
Figure 42. Global Particle Therapy Market Share Forecast by Application (2023-2028)
Figure 43. North America Particle Therapy Sales Market Share by Type (2017-2028)
Figure 44. North America Particle Therapy Sales Market Share by Application (2017-2028)
Figure 45. North America Particle Therapy Revenue Market Share by Country (2017-2028)
Figure 46. United States Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Particle Therapy Sales Market Share by Type (2017-2028)
Figure 50. Europe Particle Therapy Sales Market Share by Application (2017-2028)
Figure 51. Europe Particle Therapy Revenue Market Share by Country (2017-2028)
Figure 52. Germany Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Particle Therapy Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Particle Therapy Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Particle Therapy Revenue Market Share by Region (2017-2028)
Figure 60. China Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Particle Therapy Sales Market Share by Type (2017-2028)
Figure 67. South America Particle Therapy Sales Market Share by Application (2017-2028)
Figure 68. South America Particle Therapy Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Particle Therapy Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Particle Therapy Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Particle Therapy Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Particle Therapy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source


More Publications